Skip to content

Clinical trials

Phase 1/2 Triple Negative Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20152
20161
20182
20192
20203
20211
20223
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Terminated5
Active, not recruiting4
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
BicycleTx Limited2
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
Eisai Inc.1
Eisai Limited1
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1
Genmab1
Kymab Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms19
Carcinoma, Non-Small-Cell Lung13
Squamous Cell Carcinoma of Head and Neck8
Stomach Neoplasms8
Ovarian Neoplasms7
Carcinoma, Renal Cell5
Colorectal Neoplasms5
Melanoma5
Breast Neoplasms4
Endometrial Neoplasms4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.